Connor MP, Prathapa N, Frey NV, Gill SI, et al. Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia. Haematologica 2024 Apr 18. doi: 10.3324/haematol.2024.285275.
PMID: 38634143